Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Purpose
to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI)
Division
Global Development, Global Health
Date
November 2011
Region Served
GLOBAL
Committed amount
$3,093,402
Grant topic
Discovery and Translational Sciences, Polio
Duration (months)
111
Grantee location
Atlanta, Georgia, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.